You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 32 No. 9, September 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (118)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Basis for Amine Hypotheses in Affective Disorders

A Critical Evaluation

Ross J. Baldessarini, MD

Arch Gen Psychiatry. 1975;32(9):1087-1093.


Abstract

• A leading hypothesis concerning a biological basis of the affectove disorders is that altered metabolism of brain amines may underlie the cause or pathophysiology of these conditions. Features of affective illnesses supporting biological hypotheses include the somatic symptoms, diurnal rhythm, and apparent "endogenicity" of many severe depressions, and evidence of a genetic basis of manic-depressive illness. Development and preclinical study of medical therapies for the disorders substantially supported a relationship between mood-disturbances and neurotransmitters and stimulated considerable advances in the physiology and pharmacology of central synaptic neurotransmission. Unfortunately, studies of amine metabolism in patients have not provided consistent support for the amine hypotheses. Moreover, these hypotheses have not led to a coherent biological theory of abnormal behavior, to an objective basis for differential diagnosis, or to the rational development of treatments more effective or safer than those known.



Author Affiliations

From the Psychiatric Research Laboratories, Massachusetts General Hospital, and the Department of Psychiatry, Harvard Medical School, Boston.


Footnotes

Accepted for publication April 25, 1975.

Read in part before an American Association for the Advancement of Science symposium, San Francisco, Feb 27, 1974.

Reprint requests to the Neuropharmacology Laboratory, Massachusetts General H ospital, Fruit Street, Boston, MA 02114 (Dr. Baldessarini).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Etiologic Features of Depression in Adults
Council on Scientific Affairs, American Medical As
Arch Fam Med 1993;2:76-83.
ABSTRACT  

{alpha}2-Adrenergic Receptor Sensitivity in Depression: The Plasma MHPG, Behavioral, and Cardiovascular Responses to Yohimbine
Heninger et al.
Arch Gen Psychiatry 1988;45:718-726.
ABSTRACT  

Prostaglandin Receptor Sensitivity in Psychiatric Disorders
Kanof et al.
Arch Gen Psychiatry 1986;43:987-993.
ABSTRACT  

The Neurology of Depression: Cognitive and Behavioral Deficits With Focal Findings in Depression and Resolution After Electroconvulsive Therapy
Freeman et al.
Arch Neurol 1985;42:289-291.
ABSTRACT  

Hemispheric Asymmetry in the Expression of Positive and Negative Emotions: Neurologic Evidence
Sackeim et al.
Arch Neurol 1982;39:210-218.
ABSTRACT  

Platelet Monoamine Oxidase Activity in Relatives of Alcoholics: Preliminary Study With Matched Control Subjects
Schuckit et al.
Arch Gen Psychiatry 1982;39:137-140.
ABSTRACT  

Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding
Kendall et al.
Science 1981;211:1183-1185.
ABSTRACT  

Improvement of Depression by REM Sleep Deprivation: New Findings and a Theory
Vogel et al.
Arch Gen Psychiatry 1980;37:247-253.
ABSTRACT  

Cerebral norepinephrine: influence on cortical oxidative metabolism in situ
Harik et al.
Science 1979;206:69-71.
ABSTRACT  

Substitute and Alternative Neurotransmitters in Neuropsychiatric Illness
Baldessarini and Fischer
Arch Gen Psychiatry 1977;34:958-964.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Dopamine and Serotonin Metabolism in Neuropsychiatrically Disturbed Children: CSF Homovanillic Acid and 5-Hydroxyindoleacetic Acid
Cohen et al.
Arch Gen Psychiatry 1977;34:545-550.
ABSTRACT  

Increased Norepinephrine Levels and Decreased Dopamine-{beta}-Hydroxylase Activity in Primary Autism
Lake et al.
Arch Gen Psychiatry 1977;34:553-556.
ABSTRACT  

Monoamine Metabolism in Human Brain
Robinson et al.
Arch Gen Psychiatry 1977;34:89-92.
ABSTRACT  

5-HIAA in the Cerebrospinal Fluid: A Biochemical Suicide Predictor?
Asberg et al.
Arch Gen Psychiatry 1976;33:1193-1197.
ABSTRACT  

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
Shopsin et al.
Arch Gen Psychiatry 1976;33:811-819.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.